Edinburgh, United Kingdom

Alan Christopher Boyd

USPTO Granted Patents = 1 



Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Christopher Boyd: Innovator in Gene Therapy

Introduction

Alan Christopher Boyd is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of gene therapy, particularly through his innovative work on lentiviral vectors. His research focuses on developing methods to treat respiratory tract diseases, showcasing his commitment to advancing medical science.

Latest Patents

Alan Christopher Boyd holds a patent related to lentiviral gene transfer vectors. This invention involves vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus. The patent includes a promoter and a transgene, along with methods for creating these vectors. The application of this invention is particularly relevant in gene therapy for treating respiratory tract diseases such as Cystic Fibrosis (CF). He has 1 patent to his name.

Career Highlights

Throughout his career, Alan has worked with various companies, including Ip2ipo Innovations Limited and Id Pharma Co., Ltd. His experience in these organizations has allowed him to further his research and contribute to the development of innovative therapies.

Collaborations

Alan has collaborated with esteemed colleagues such as Eric Walter Frederick Wolfgang Alton and Uta Griesenbach. These partnerships have enriched his research and expanded the impact of his work in the field of gene therapy.

Conclusion

Alan Christopher Boyd is a pioneering inventor whose work in lentiviral vectors has the potential to transform gene therapy for respiratory diseases. His contributions reflect a dedication to improving health outcomes through innovative scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…